top of page
gradientForSurfBreak.png

Item List

Yahoo
Invitae Launches Rare Patient Network for Pediatric Patients With Rare Neurodevelopmental Diseases

Invitae (NYSE: NVTA), a leading medical genetics company, today announced the launch of the Rare Patient Network expanding Invitae's Ciitizen platform to all patients with pediatric epilepsy and/or developmental delay with plans to include other conditions in the coming months. By engaging with a broader community, Invitae, a leader in the rare pediatric neurodevelopmental field, aims to create value for significantly more patients with rare diseases.

Recent Posts

Portfolio Company

Carlsmed.png

xCures showcases the Power of its Real-time Clinical data platform at ASCO Annua ...

Newswire EIN

Portfolio Company

Carlsmed.png

Tracy MacNeal Of Materna Medical On Five Things We Must Do to Improve the US Hea ...

Medium

Portfolio Company

Carlsmed.png

UptimeHealth teams up with Dental Health Products, supporting access to vital su ...

Newswire EIN

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page